Human Blood Plasma Fractionation Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Human Blood Plasma Fractionation Market size is expected to grow at an annual average of 7% during 2022-2028. Fractionation is a process performed to separate a certain amount of a mixture. Plasma is also the fluid component of blood, which is fractionated to obtain various plasma derivatives such as albumin and immunoglobulins. These derived plasma products have therapeutic effects and are used in the treatment of various plasma-related disorders. For example, coagulation factor VIII is a plasma derivative used for the treatment and prevention of hemophilia. It is also used to prevent excessive blood loss during surgery. Similarly, immunoglobulins are used to treat primary and secondary immunodeficiency.

The following segmentation are covered in this report:

By Application

• Neurology
• Immunology
• Hematology
• Critical care
• Pulmonology
• Hemato-oncology
• Rheumatology
• Other Applications

By Product

• Immunoglobulins
• Intravenous Immunoglobulins
• Subcutaneous Immunoglobulins
• Other Immunoglobulins
• Coagulation Factor Concentrates
• Factor VIII
• Factor IX
• Von Willebrand Factor
• Prothrombin Complex Concentrate
• Fibrinogen Concentrates
• Factor XIII
• Albumin
• Protease Inhibitors
• Other Products

 By End User

• Hospitals & Clinics
• Clinical Research Laboratories
• Academic Institutes 

Company Profile

• Bio Products Laboratory
• Biotest AG
• China Biologic Products
• CSL Behring
• Grifols S.A.
• Takeda Pharmaceutical Company Ltd
• Kedrion S.p.A
• Octapharma
• Shanghai RAAS Blood Products

Scope of the report

The research study analyses the Human Blood Plasma Fractionation Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Human Blood Plasma Fractionation Market Report

• What was the Human Blood Plasma Fractionation Market size in 2022 and 2028; what are the estimated growth trends and market forecast (2022-2028)
• What will be the CAGR of Market during the forecast period (2022-2028)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
• Which manufacturer/vendor/players in the Human Blood Plasma Fractionation Market was the market leader in 2022?